DOC - Global Tuberculosis Institute
... 7. Which of the following is NOT a symptom of active pulmonary TB disease? a. productive, prolonged cough b. fever c. diarrhea d. night sweats e. weight loss 8. Miliary TB occurs when tubercle bacilli: a. enter the blood stream and are carried to all parts of the body b. convert from an active state ...
... 7. Which of the following is NOT a symptom of active pulmonary TB disease? a. productive, prolonged cough b. fever c. diarrhea d. night sweats e. weight loss 8. Miliary TB occurs when tubercle bacilli: a. enter the blood stream and are carried to all parts of the body b. convert from an active state ...
Disease Process - De Anza College
... Types of Infectious Diseases • Acute -develops rapidly but lasts for short time- influenza • Chronic disease -develops more slowly and continues or recurs for long periods -TB, hepatitis B • Latent- agent remains inactive for a time and later becomes active-shingles ...
... Types of Infectious Diseases • Acute -develops rapidly but lasts for short time- influenza • Chronic disease -develops more slowly and continues or recurs for long periods -TB, hepatitis B • Latent- agent remains inactive for a time and later becomes active-shingles ...
presentation
... infections. The viral genome may become incorporated into the host DNA or remain ...
... infections. The viral genome may become incorporated into the host DNA or remain ...
Haywood County Safety Training
... Hepatitis C (HCV) • Hepatitis C is the most common chronic bloodborne infection in the United States. • Symptoms include: Jaundice, fatigue, abdominal pain, loss of appetite, intermittent nausea and vomiting. • May lead to chronic liver disease and death. ...
... Hepatitis C (HCV) • Hepatitis C is the most common chronic bloodborne infection in the United States. • Symptoms include: Jaundice, fatigue, abdominal pain, loss of appetite, intermittent nausea and vomiting. • May lead to chronic liver disease and death. ...
Epidemiology_Kyasanur Forest Disease
... By the bite of infective ticks (nymphal stage) Humans are dead end in the natural cycle ...
... By the bite of infective ticks (nymphal stage) Humans are dead end in the natural cycle ...
Exposure Control Protocol Exposure Risk Assessment Form Name:
... B. No Risk: _____Puncture wound with sterile sharp. _____Splash of blood/body fluid to intact skin. The above two categories do not indicate an exposure; however the recommended preventive treatment for all healthcare employees is to: Provide First Aid Update tetanus if skin was punctured and la ...
... B. No Risk: _____Puncture wound with sterile sharp. _____Splash of blood/body fluid to intact skin. The above two categories do not indicate an exposure; however the recommended preventive treatment for all healthcare employees is to: Provide First Aid Update tetanus if skin was punctured and la ...
The Chain of Infection
... 5. Protect Portal of Entry -Healthcare professionals must make sure that ports of entry are not subjected to pathogens. ...
... 5. Protect Portal of Entry -Healthcare professionals must make sure that ports of entry are not subjected to pathogens. ...
Bloodborne Pathogens Training
... --eventually develop AIDS --develop AIDS-related illness (cancer, neurological problems and other opportunistic infections) ...
... --eventually develop AIDS --develop AIDS-related illness (cancer, neurological problems and other opportunistic infections) ...
TB - Columbia University
... HIV infection Tuberculin skin test conversion Fibrotic lesions (on chest X-ray) consistent with old, healed TB Injection drug use Diabetes mellitus Prolonged high-dose corticosteroid therapy or other intensive immunosuppressive therapy Chronic renal failure Some hematologic disorders, such as leukem ...
... HIV infection Tuberculin skin test conversion Fibrotic lesions (on chest X-ray) consistent with old, healed TB Injection drug use Diabetes mellitus Prolonged high-dose corticosteroid therapy or other intensive immunosuppressive therapy Chronic renal failure Some hematologic disorders, such as leukem ...
Bloodborne Pathogens Module
... --eventually develop AIDS --develop AIDS-related illness (cancer, neurological problems and other opportunistic infections) ...
... --eventually develop AIDS --develop AIDS-related illness (cancer, neurological problems and other opportunistic infections) ...
Chapter 13 - eacfaculty.org
... the infectious agent to the appearance of first symptoms; agent is multiplying but damage is insufficient to cause symptoms; several hours to several years – prodromal stage – vague feelings of discomfort; nonspecific complaints – period of invasion – multiplies at high levels, becomes well establis ...
... the infectious agent to the appearance of first symptoms; agent is multiplying but damage is insufficient to cause symptoms; several hours to several years – prodromal stage – vague feelings of discomfort; nonspecific complaints – period of invasion – multiplies at high levels, becomes well establis ...
A cellular model for pandemic influenza outbreak simulation and
... influenza: in 1918, 1957 and 1968 causing widespread mortality especially amongst healthy people. The 1918 outbreak was the most deadly killing 20-40 million people worldwide with nearly half of these deaths in young adults in the 20-40 year age group. It is generally agreed that the world is moving ...
... influenza: in 1918, 1957 and 1968 causing widespread mortality especially amongst healthy people. The 1918 outbreak was the most deadly killing 20-40 million people worldwide with nearly half of these deaths in young adults in the 20-40 year age group. It is generally agreed that the world is moving ...
Mononucleosis
... infected. Anyone can be infected with the EBV, but very few develop illness. In the United States, illness usually occurs in older ...
... infected. Anyone can be infected with the EBV, but very few develop illness. In the United States, illness usually occurs in older ...
joint press release of the German Cancer Research Center and the
... cell’s surface. In the case of HBV, a portion of the large surface protein (L protein) in the viral envelope binds to heparan sulfate proteoglycans (HSPG) on the liver cell, and subsequently mediates uptake of the virus particle into the cell where progeny viruses are produced. ‘The effectiveness of ...
... cell’s surface. In the case of HBV, a portion of the large surface protein (L protein) in the viral envelope binds to heparan sulfate proteoglycans (HSPG) on the liver cell, and subsequently mediates uptake of the virus particle into the cell where progeny viruses are produced. ‘The effectiveness of ...
How good are we at reducing the risk? An Audit of
... ‘the provision of a targeted infant immunisation programme ...
... ‘the provision of a targeted infant immunisation programme ...
West Nile - Felicia Henderson
... traditional boundaries, causing illness in birds, horses, and humans in Europe and now the United States. It was first discovered in the U.S. in 1999 in New York City. Since that time, WNV has been detected in humans, animals, and mosquitoes in 47 states from coast to coast. West Nile virus is a dis ...
... traditional boundaries, causing illness in birds, horses, and humans in Europe and now the United States. It was first discovered in the U.S. in 1999 in New York City. Since that time, WNV has been detected in humans, animals, and mosquitoes in 47 states from coast to coast. West Nile virus is a dis ...
- Committed to Cure
... that people with hepatitis C have access to the best treatments. She is currently lobbying for a National Action Plan on hepatitis C for Sweden, as well as working to establish international contacts and networks. George Kalamitsis (Greece) is the founding member and President of the Hellenic Liver ...
... that people with hepatitis C have access to the best treatments. She is currently lobbying for a National Action Plan on hepatitis C for Sweden, as well as working to establish international contacts and networks. George Kalamitsis (Greece) is the founding member and President of the Hellenic Liver ...
Bloodborne Pathogen Training
... Do not tamper or alter Do not activate safety device by hand, use hard surface to activate Dispose of in sharps container Report device failure to infection control ...
... Do not tamper or alter Do not activate safety device by hand, use hard surface to activate Dispose of in sharps container Report device failure to infection control ...
In case you get sick Health and Emergency Contact Information
... Is meningitis contagious? Yes, bacterial meningitis is highly contagious. The bacteria are spread through the exchange of respiratory and throat secretions (i.e., coughing, kissing). Fortunately, none of the bacteria that cause meningitis are as contagious as things like the common cold or the flu, ...
... Is meningitis contagious? Yes, bacterial meningitis is highly contagious. The bacteria are spread through the exchange of respiratory and throat secretions (i.e., coughing, kissing). Fortunately, none of the bacteria that cause meningitis are as contagious as things like the common cold or the flu, ...
Hepatitis B Fact Sheet
... for treatment. Role of viral load While a viral load greater than 300 copies/mL increases the risk of liver damage, researchers continue to use 20,000 IU/mL for HBeAgpositive patients and 2,000 IU/mL for HBeAg-negative patients as the thresholds for initiating treatment. But many patients have fluct ...
... for treatment. Role of viral load While a viral load greater than 300 copies/mL increases the risk of liver damage, researchers continue to use 20,000 IU/mL for HBeAgpositive patients and 2,000 IU/mL for HBeAg-negative patients as the thresholds for initiating treatment. But many patients have fluct ...
The Chain of Infection
... 5. Protect Portal of Entry -Health professionals must make sure that ports of entry are not subjected to pathogens. ...
... 5. Protect Portal of Entry -Health professionals must make sure that ports of entry are not subjected to pathogens. ...
The Chain of Infection
... 5. Protect Portal of Entry -Health professionals must make sure that ports of entry are not subjected to pathogens. ...
... 5. Protect Portal of Entry -Health professionals must make sure that ports of entry are not subjected to pathogens. ...
10 INFECTIOUS BURSAL DISEASE 1. Definition Infectious bursal
... it becomes small. Animals are incoordinated and may be recumbent. Deaths begin to occur at about the third day of clinical illness. Mortality is usually around 10% but may be as high as 30%. One of the major clinical problems with IBD is that they remain immunosuppressed ...
... it becomes small. Animals are incoordinated and may be recumbent. Deaths begin to occur at about the third day of clinical illness. Mortality is usually around 10% but may be as high as 30%. One of the major clinical problems with IBD is that they remain immunosuppressed ...
VIRAL DISEASES
... Clinical signs may be so slight that they pass unnoticed, while definite clinical signs may be diagnosed in some dogs. A small minority come down with severe clinical signs in that case there is high mortality. In endemic areas sporadic epidemics may occur. Young puppies 3-6 months are most suscep ...
... Clinical signs may be so slight that they pass unnoticed, while definite clinical signs may be diagnosed in some dogs. A small minority come down with severe clinical signs in that case there is high mortality. In endemic areas sporadic epidemics may occur. Young puppies 3-6 months are most suscep ...
Hepatitis C Infection
... American Association for the Study of Liver Diseases/Infectious Diseases Society of America, with International Antiviral Society–USA. Recommendations for testing, managing, and treating hepatitis C. Available at: http://www.hcvguidelines.org/full-report-view. Accessed July 24, 2014. Centers for Dis ...
... American Association for the Study of Liver Diseases/Infectious Diseases Society of America, with International Antiviral Society–USA. Recommendations for testing, managing, and treating hepatitis C. Available at: http://www.hcvguidelines.org/full-report-view. Accessed July 24, 2014. Centers for Dis ...
Hepatitis C
Hepatitis C is an infectious disease affecting primarily the liver, caused by the hepatitis C virus (HCV). The infection is often asymptomatic, but chronic infection can lead to scarring of the liver and ultimately to cirrhosis, which is generally apparent after many years. In some cases, those with cirrhosis will go on to develop liver failure, liver cancer, or life-threatening esophageal and gastric varices.HCV is spread primarily by blood-to-blood contact associated with intravenous drug use, poorly sterilized medical equipment, and transfusions. An estimated 150–200 million people worldwide are infected with hepatitis C. The existence of hepatitis C – originally identifiable only as a type of non-A non-B hepatitis – was suggested in the 1970s and proven in 1989. Hepatitis C infects only humans and chimpanzees. It is one of five known hepatitis viruses: A, B, C, D, and E.The virus persists in the liver in about 85% of those infected. This chronic infection can be treated with medication: the standard therapy is a combination of peginterferon and ribavirin, with either boceprevir or telaprevir added in some cases. Overall, 50–80% of people treated are cured. Those who develop cirrhosis or liver cancer may require a liver transplant. Hepatitis C is the leading reason for liver transplantation, though the virus usually recurs after transplantation. No vaccine against hepatitis C is available. About 343,000 deaths due to liver cancer from hepatitis C occurred in 2013, up from 198,000 in 1990. An additional 358,000 in 2013 occurred due to cirrhosis.